Alcohol-Related Cirrhosis Carries Higher Mortality Risk Than MASH-Related Cirrhosis

Research presented at Digestive Disease Week on May 2, 2026, indicates that alcohol-related cirrhosis is associated with a twofold higher mortality risk compared to cirrhosis caused by metabolic dysfunction-associated steatohepatitis (MASH), even when the severity of the disease is matched between the two groups.

The findings suggest that the etiology of the liver damage plays a significant role in patient outcomes, independent of how advanced the cirrhosis has progressed.

Differences in Complications and Risks

Beyond the increased mortality rate, the data presented at the conference showed that patients with alcohol-related cirrhosis experienced significantly higher rates of portal vein thrombosis than those with MASH-related cirrhosis.

Portal vein thrombosis occurs when a blood clot forms in the portal vein, which carries blood from the gastrointestinal tract to the liver. This complication can exacerbate portal hypertension and increase the risk of further liver complications.

However, the research noted that some outcomes remained consistent across both types of cirrhosis. When matching for disease severity, the rates of liver cancer were similar between the alcohol-related and MASH-related groups.

there was no immediate difference in transplant rates between the two cohorts once severity was matched.

Understanding MASH and Alcohol-Related Cirrhosis

Cirrhosis is the late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions. The research compared two primary drivers of liver failure: alcohol consumption and metabolic dysfunction.

Metabolic dysfunction-associated steatohepatitis, or MASH, is a progressive form of fatty liver disease. It is characterized by the accumulation of fat in the liver accompanied by inflammation and cellular damage. MASH is closely linked to metabolic syndrome, which often includes obesity, type 2 diabetes, and high blood pressure.

The terminology for this condition was recently updated from non-alcoholic steatohepatitis (NASH) to MASH to better reflect the metabolic drivers of the disease and remove stigmatizing language regarding alcohol use.

Alcohol-related cirrhosis results from long-term, excessive alcohol consumption, which causes inflammation and the gradual replacement of healthy liver tissue with scar tissue.

Clinical Implications of Severity Matching

A critical aspect of this presentation was the use of severity matching. In clinical liver research, severity is often measured by scores such as the Model for End-Stage Liver Disease (MELD), which uses laboratory values to predict the risk of death.

By matching patients with similar severity scores, researchers can isolate the impact of the cause of the disease. The fact that alcohol-related cirrhosis maintained a twofold higher mortality risk despite similar severity scores suggests that the underlying nature of alcohol-induced damage may be more aggressive or associated with comorbidities that increase the risk of death.

A presenter at Digestive Disease Week noted that Alcohol-related cirrhosis and MASH-related cirrhosis are often discussed within the broad framework of liver disease, but these findings highlight distinct prognostic differences between the two.